• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

动物模型与人类迟发性运动障碍的相关性。

Relevance of animal models to human tardive dyskinesia.

机构信息

Faculty of Dental Medicine, University of Montreal, PO Box 6128, Succ, Centre-ville, Montreal, QC H3C 3J7, Canada.

出版信息

Behav Brain Funct. 2012 Mar 9;8:12. doi: 10.1186/1744-9081-8-12.

DOI:10.1186/1744-9081-8-12
PMID:22404856
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3338072/
Abstract

Tardive dyskinesia remains an elusive and significant clinical entity that can possibly be understood via experimentation with animal models. We conducted a literature review on tardive dyskinesia modeling. Subchronic antipsychotic drug exposure is a standard approach to model tardive dyskinesia in rodents. Vacuous chewing movements constitute the most common pattern of expression of purposeless oral movements and represent an impermanent response, with individual and strain susceptibility differences. Transgenic mice are also used to address the contribution of adaptive and maladaptive signals induced during antipsychotic drug exposure. An emphasis on non-human primate modeling is proposed, and past experimental observations reviewed in various monkey species. Rodent and primate models are complementary, but the non-human primate model appears more convincingly similar to the human condition and better suited to address therapeutic issues against tardive dyskinesia.

摘要

迟发性运动障碍仍然是一种难以捉摸且意义重大的临床病症,通过动物模型实验可能有助于理解。我们对迟发性运动障碍建模进行了文献回顾。亚慢性抗精神病药物暴露是在啮齿动物中模拟迟发性运动障碍的标准方法。空嚼运动构成了无目的口腔运动表达最常见的模式,代表了一种暂时的反应,存在个体和品系易感性差异。转基因小鼠也被用于解决抗精神病药物暴露过程中适应性和失调性信号的贡献。本文强调了非人类灵长类动物模型的重要性,并回顾了各种猴子物种中的过去实验观察结果。啮齿动物和灵长类动物模型是互补的,但非人类灵长类动物模型似乎更能令人信服地模拟人类疾病状况,更适合解决迟发性运动障碍的治疗问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acc5/3338072/6634c178b005/1744-9081-8-12-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acc5/3338072/5f2fc9c6b4be/1744-9081-8-12-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acc5/3338072/6634c178b005/1744-9081-8-12-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acc5/3338072/5f2fc9c6b4be/1744-9081-8-12-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acc5/3338072/6634c178b005/1744-9081-8-12-2.jpg

相似文献

1
Relevance of animal models to human tardive dyskinesia.动物模型与人类迟发性运动障碍的相关性。
Behav Brain Funct. 2012 Mar 9;8:12. doi: 10.1186/1744-9081-8-12.
2
Parallels between behavioral and neurochemical variability in the rat vacuous chewing movement model of tardive dyskinesia.迟发性运动障碍大鼠空嚼运动模型中行为和神经化学变异性的比较。
Behav Brain Res. 2012 Jun 1;231(2):323-36. doi: 10.1016/j.bbr.2012.03.045. Epub 2012 Apr 6.
3
Co-Expression of Tardive Dyskinesia and Drug-Induced Parkinsonism in Rats Chronically Treated With Haloperidol.长期接受氟哌啶醇治疗的大鼠中迟发性运动障碍与药物性帕金森综合征的共表达。
Neuropsychopharmacol Rep. 2025 Mar;45(1):e12524. doi: 10.1002/npr2.12524.
4
Animal models of tardive dyskinesia--a review.迟发性运动障碍的动物模型——综述
Indian J Physiol Pharmacol. 2001 Apr;45(2):148-60.
5
Distinguishing akathisia and tardive dyskinesia: a review of the literature.区分静坐不能和迟发性运动障碍:文献综述
J Clin Psychopharmacol. 1983 Dec;3(6):343-50.
6
Animal models of tardive dyskinesia.迟发性运动障碍的动物模型。
Int Rev Neurobiol. 2011;98:265-87. doi: 10.1016/B978-0-12-381328-2.00011-0.
7
Spontaneous and tardive dyskinesias: clinical and laboratory studies.
J Clin Psychiatry. 1985 Apr;46(4 Pt 2):42-7.
8
Dopamine D(1A) receptor function in a rodent model of tardive dyskinesia.迟发性运动障碍啮齿动物模型中的多巴胺D(1A)受体功能
Neuroscience. 2000;101(3):629-35. doi: 10.1016/s0306-4522(00)00412-7.
9
Oxidative stress and the antipsychotic-induced vacuous chewing movement model of tardive dyskinesia: evidence for antioxidant-based prevention strategies.氧化应激与抗精神病药物诱发的迟发性运动障碍的空嚼运动模型:基于抗氧化剂的预防策略的证据
Psychopharmacology (Berl). 2014 Jun;231(11):2237-49. doi: 10.1007/s00213-014-3582-6. Epub 2014 Apr 22.
10
Noradrenergic effects in tardive dyskinesia, akathisia and pseudoparkinsonism via the limbic system and basal ganglia.
Prog Neuropsychopharmacol Biol Psychiatry. 1988;12(6):849-64. doi: 10.1016/0278-5846(88)90081-4.

引用本文的文献

1
Cannabigerol Mitigates Haloperidol-Induced Vacuous Chewing Movements in Mice.大麻二酚减轻小鼠中由氟哌啶醇诱导的空嚼运动。
Neurotox Res. 2024 Dec 19;43(1):2. doi: 10.1007/s12640-024-00724-0.
2
Molecular and Behavioral Neuroprotective Effects of Clavulanic Acid and Crocin in Haloperidol-Induced Tardive Dyskinesia in Rats.克拉维酸和藏红花素对大鼠氟哌啶醇诱导的迟发性运动障碍的分子和行为神经保护作用
Mol Neurobiol. 2025 Apr;62(4):5156-5182. doi: 10.1007/s12035-024-04566-x. Epub 2024 Nov 9.
3
Animal models of Parkinson's disease: bridging the gap between disease hallmarks and research questions.

本文引用的文献

1
Continuous, but not intermittent, antipsychotic drug delivery intensifies the pursuit of reward cues.持续而非间歇性的抗精神病药物输送会加剧对奖励线索的追求。
Neuropsychopharmacology. 2011 May;36(6):1248-59. doi: 10.1038/npp.2011.10. Epub 2011 Feb 16.
2
Incidence of tardive dyskinesia with atypical versus conventional antipsychotic medications: a prospective cohort study.迟发性运动障碍与非典型与传统抗精神病药物的发生率:一项前瞻性队列研究。
J Clin Psychiatry. 2010 Apr;71(4):463-74. doi: 10.4088/JCP.07m03890yel. Epub 2010 Feb 9.
3
From the MPTP-treated primate to the treatment of motor complications in Parkinson's disease.
帕金森病动物模型:弥合疾病特征与研究问题之间的差距。
Transl Neurodegener. 2023 Jul 19;12(1):36. doi: 10.1186/s40035-023-00368-8.
4
Genetic Factors Associated With Tardive Dyskinesia: From Pre-clinical Models to Clinical Studies.与迟发性运动障碍相关的遗传因素:从临床前模型到临床研究
Front Pharmacol. 2022 Jan 24;12:834129. doi: 10.3389/fphar.2021.834129. eCollection 2021.
5
Management of Tardive Syndrome: Medications and Surgical Treatments.迟发性运动障碍的治疗:药物治疗和手术治疗。
Neurotherapeutics. 2020 Oct;17(4):1694-1712. doi: 10.1007/s13311-020-00898-3.
6
Current Methods for the Treatment and Prevention of Drug-Induced Parkinsonism and Tardive Dyskinesia in the Elderly.老年人药物性帕金森综合征和迟发性运动障碍的当前治疗与预防方法
Drugs Aging. 2018 Nov;35(11):959-971. doi: 10.1007/s40266-018-0590-y.
7
Tardive Dyskinesia Associated with Atypical Antipsychotics: Prevalence, Mechanisms and Management Strategies.与非典型抗精神病药物相关的迟发性运动障碍:患病率、发病机制和管理策略。
CNS Drugs. 2018 Feb;32(2):135-147. doi: 10.1007/s40263-018-0494-8.
8
Therapeutic Perspective on Tardive Syndrome with Special Reference to Deep Brain Stimulation.迟发性综合征的治疗前景:特别提及脑深部电刺激术
Front Psychiatry. 2016 Dec 26;7:207. doi: 10.3389/fpsyt.2016.00207. eCollection 2016.
9
Striatal cholinergic interneurons and D2 receptor-expressing GABAergic medium spiny neurons regulate tardive dyskinesia.纹状体胆碱能中间神经元和表达D2受体的γ-氨基丁酸能中型多棘神经元调节迟发性运动障碍。
Exp Neurol. 2016 Dec;286:32-39. doi: 10.1016/j.expneurol.2016.09.009. Epub 2016 Sep 19.
10
Polymorphism of the 3'-UTR of the dopamine transporter gene (DAT) in New World monkeys.新大陆猴多巴胺转运体基因(DAT)3'-非翻译区的多态性
Primates. 2017 Jan;58(1):169-178. doi: 10.1007/s10329-016-0560-0. Epub 2016 Aug 8.
从 MPTP 处理的灵长类动物到帕金森病运动并发症的治疗。
Parkinsonism Relat Disord. 2009 Dec;15 Suppl 4:S18-23. doi: 10.1016/S1353-8020(09)70829-6.
4
Association of the orphan nuclear receptor NR4A1 with tardive dyskinesia.孤儿核受体NR4A1与迟发性运动障碍的关联。
Psychiatr Genet. 2010 Feb;20(1):39-43. doi: 10.1097/YPG.0b013e3283351221.
5
D2-receptor upregulation is dependent upon temporal course of D2-occupancy: a longitudinal [11C]-raclopride PET study in cats.D2受体上调取决于D2占有率的时间进程:一项针对猫的纵向[11C] - 雷氯必利PET研究。
Neuropsychopharmacology. 2009 Feb;34(3):662-71. doi: 10.1038/npp.2008.116. Epub 2008 Aug 6.
6
Less is more: antipsychotic drug effects are greater with transient rather than continuous delivery.少即是多:抗精神病药物短暂给药的效果优于持续给药。
Biol Psychiatry. 2008 Jul 15;64(2):145-52. doi: 10.1016/j.biopsych.2008.01.010. Epub 2008 Mar 4.
7
Modeling tardive dyskinesia: predictive 5-HT2C receptor antagonist treatment.迟发性运动障碍建模:预测性5-羟色胺2C受体拮抗剂治疗
Neurotox Res. 2007 Jan;11(1):41-50. doi: 10.1007/BF03033481.
8
The effect of atypical versus typical antipsychotics on tardive dyskinesia: a naturalistic study.非典型抗精神病药物与典型抗精神病药物对迟发性运动障碍的影响:一项自然主义研究。
Eur Arch Psychiatry Clin Neurosci. 2007 Apr;257(3):169-72. doi: 10.1007/s00406-006-0705-z. Epub 2006 Dec 5.
9
AMPA receptor subunit and splice variant expression in the DLPFC of schizophrenic subjects and rhesus monkeys chronically administered antipsychotic drugs.慢性服用抗精神病药物的精神分裂症患者和恒河猴背外侧前额叶皮质中AMPA受体亚基及剪接变体的表达
Schizophr Res. 2007 Feb;90(1-3):28-40. doi: 10.1016/j.schres.2006.10.004. Epub 2006 Dec 1.
10
Region specific regulation of NR1 in rhesus monkeys following chronic antipsychotic drug administration.慢性抗精神病药物给药后恒河猴中NR1的区域特异性调节。
Biol Psychiatry. 2006 Sep 15;60(6):659-62. doi: 10.1016/j.biopsych.2006.03.044. Epub 2006 Jun 27.